The chemokine ligand CCL2 or monocyte chemoattractant protein 1 (MCP-1) mediates the trafficking of immune cells into the TME in many types of malignancies, such as melanoma, colorectal, breast, prostate and pancreatic cancer (32). The gene discussed is CCL2; the disease is melanoma.